Siegfried Holding AG SFZN

Morningstar Rating
CHF 1,150.00 −12.00 (1.03%)
View Full Chart

Company Report

Price vs Fair Value

SFZN is trading at a 255% premium.
Price
CHF 1,150.00
Fair Value
CHF 3,985.00
Uncertainty
Medium
1-Star Price
CHF 5,135.00
5-Star Price
CHF 481.00
Economic Moat
Rjljnz
Capital Allocation
Ctlpnwvyc

Bulls Say, Bears Say

Bulls

As drug manufacturing continues to become more complex, the long-term outlook looks bright as biotechnology and pharmaceutical firms will continue to be more reliant on outsourced manufacturing.

Bears

Siegfried is vulnerable to facility closures whether from natural disasters or manufacturing issues, and a warning letter from the FDA or other regulatory agency can result in manufacturing delays or closures.

News

Trading Information

Previous Close Price
CHF 1,162.00
Day Range
CHF 1,148.001,160.00
52-Week Range
CHF 655.001,188.00
Bid/Ask
CHF 1,146.00 / CHF 1,190.00
Market Cap
CHF 4.99 Bil
Volume/Avg
3,609 / 6,894

Key Statistics

Price/Earnings (Normalized)
35.24
Price/Sales
3.88
Dividend Yield (Trailing)
0.31%
Dividend Yield (Forward)
0.31%
Total Yield
0.50%

Company Profile

Siegfried Holding is a global contract development and manufacturing organization, or CDMO. Siegfried derives its revenue primarily from long-term supply agreements with biotechnology and pharmaceutical customers. Siegfried develops and manufactures active pharmaceutical ingredients, finished dosage forms (tablets, capsules, sterile vials, ampules, cartridges, and ointments), and viral vectors. Siegfried provides these services throughout the entire drug lifecycle, including chemical and analytical development, pilot manufacturing, and commercial-scale manufacturing. Siegfried has a large global footprint with 12 production sites on three continents.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Mid Growth
Total Number of Employees
3,797

Competitors

Valuation

Metric
SFZN
LONN
02269
Price/Earnings (Normalized)
35.2433.4120.61
Price/Book Value
5.764.151.62
Price/Sales
3.885.823.70
Price/Cash Flow
25.2929.2521.00
Price/Earnings
SFZN
LONN
02269

Financial Strength

Metric
SFZN
LONN
02269
Quick Ratio
1.191.382.40
Current Ratio
2.702.042.91
Interest Coverage
17.616.8823.45
Quick Ratio
SFZN
LONN
02269

Profitability

Metric
SFZN
LONN
02269
Return on Assets (Normalized)
7.69%5.18%7.48%
Return on Equity (Normalized)
18.01%9.32%11.09%
Return on Invested Capital (Normalized)
11.28%7.38%8.36%
Return on Assets
SFZN
LONN
02269

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
KzdddlynSnvls$88.3 Bil
Merck KGaA ADR
MKKGY
YqpqvbqfghHjbcrd$78.0 Bil
Haleon PLC ADR
HLN
TmjzbmmwJwzt$48.4 Bil
Viatris Inc
VTRS
CtkhrnbmFpzl$13.8 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
DdbwmxztJfqbg$13.5 Bil
Catalent Inc
CTLT
LjtmpfxCvbzgq$10.9 Bil
Prestige Consumer Healthcare Inc
PBH
JlpzmclKjnrby$3.5 Bil
Perrigo Co PLC
PRGO
XvwjmwwMhhk$3.5 Bil
Green Thumb Industries Inc
GTBIF
RsrqhsktVbwz$2.5 Bil
Curaleaf Holdings Inc
CURLF
ZdlpsphHdqfp$2.3 Bil

Sponsor Center